#Blog

Access
All Articles

Radio Compass Blog

Cipla in FDA trouble; FDA-backed cannabis drug posts strong sales in launch year

This week, Phispers brings you an update on the mysterious respiratory infection as over 500 people get infected by the coronavirus worldwide, killing 17 people in China. Companies like Celltrion, AstraZeneca and Astella have announced major invest...
2020-01-23

https://www.pharmacompass.com/radio-compass-blog/cipla-in-fda-trouble-fda-backed-cannabis-drug-posts-strong-sales-in-launch-year

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1503
Share Share info

#PharmaFlow

Access
Interactive
Dashboard

Radio Data Compilation Dashboards

DMF submissions in 2019: India maintains bulk drug supply supremacy to US

At PharmaCompass, we highlighted the significance of India in the global active pharmaceutical ingredient (API) supply chain last week with our list of generic drug facilities registered with the US Food and Drug Administration (FDA). Our com...
2020-01-23

https://www.pharmacompass.com/radio-compass-blog/dmf-submissions-in-2019-india-maintains-bulk-drug-supply-supremacy-to-us

#PharmaFlow by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1442
Share Share info

#PharmaFlow

Access
Interactive
Dashboard

Radio Data Compilation Dashboards

US generic drug supply chain continues to shrink

The number of facilities registered with the US Food and Drug Administration (FDA) to supply generic drugs has shrunk year after year. This week, PharmaCompass analyzed the FDA database of facilities that had paid the user fee under the Gene...
2020-01-16

https://www.pharmacompass.com/radio-compass-blog/us-generic-drug-supply-chain-continues-to-shrink

#PharmaFlow by PHARMACOMPASS PharmaCompass on Linkedin
Views: 3305
Share Share info

#Blog

Access
All Articles

Radio Compass Blog

China to work with EU on aligning API standards; Lupin stumbles with FDA yet again

This week, Phispers has news from China, where its drug regulator said it would work with European Commission’s drug regulatory bodies to identify similarities and differences between Chinese and EU regulatory systems for APIs.  In the US...
2020-01-16

https://www.pharmacompass.com/radio-compass-blog/china-to-work-with-eu-on-aligning-api-standards-lupin-stumbles-with-fda-yet-again

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 825
Share Share info

#Blog

Access
All Articles

Radio Compass Blog

2020 begins with drug price increases in US and mysterious illness in China

This week in Phispers, we have news about pharmaceutical companies ushering in the new year with a hike in US list prices of over 440 drugs. A peculiar respiratory illness, termed as ‘mystery pneumonia’ gripped the city of Wuhan in Chin...
2020-01-09

https://www.pharmacompass.com/radio-compass-blog/2020-begins-with-drug-price-increases-in-us-and-mysterious-illness-in-china

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1203
Share Share info

#PharmaFlow

Access
Interactive
Dashboard

Radio Data Compilation Dashboards

Novartis leads in new drug approvals; Vertex’s cystic fibrosis med holds highest sales potential

The US Food and Drug Administration’s (FDA) momentum of new drug approvals dropped marginally in 2019 — while 62 novel drugs were approved in 2018, 54 were approved in 2019. FDA’s Center for Drug Evaluation and Research (CDER) appro...
2019-12-31

https://www.pharmacompass.com/radio-compass-blog/novartis-leads-in-new-drug-approvals-vertex-s-cystic-fibrosis-med-holds-highest-sales-potential

#PharmaFlow by PHARMACOMPASS PharmaCompass on Linkedin
Views: 8596
Share Share info

#Blog

Access
All Articles

Radio Compass Blog

Data integrity concerns at Sun’s Halol plant; Merck’s Ebola vaccine bags FDA nod

This week, Phispers brings you news on Merck’s vaccine for the deadly Ebola virus disease (EVD) — Ervebo — as it bagged FDA approval. The US agency has warned against the use of opioids and certain other drugs in combination with...
2019-12-26

https://www.pharmacompass.com/radio-compass-blog/data-integrity-concerns-at-sun-s-halol-plant-merck-s-ebola-vaccine-bags-fda-nod

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1720
Share Share info

#PharmaFlow

Access
Interactive
Dashboard

Radio Data Compilation Dashboards

Cannabinoids in pharmaceutical development

The development of cannabinoids in the pharmaceutical industry has exploded over the past few years. With the gradual liberation of regulations worldwide that govern cannabis and its pharmaceutical derivatives for medicinal use, this week PharmaCo...
2019-12-19

https://www.pharmacompass.com/radio-compass-blog/cannabinoids-in-pharmaceutical-development

#PharmaFlow by PHARMACOMPASS PharmaCompass on Linkedin
Views: 2004
Share Share info

#Blog

Access
All Articles

Radio Compass Blog

Gilead loses patent case to Bristol-Myers over its CAR-T therapy; Amneal beats Dr. Reddy’s on key generic approval

This week, Phispers brings you news on Bristol-Myers Squibb winning a patent case against Gilead’s Yescarta — a US$ 11.7 billion CAR-T therapy. In the US, the Senate approved the appointment of Stephen Hahn as the FDA’s next commi...
2019-12-19

https://www.pharmacompass.com/radio-compass-blog/gilead-loses-patent-case-to-bristol-myers-over-its-car-t-therapy-amneal-beats-dr-reddy-s-on-key-generic-approval

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1059
Share Share info

#Blog

Access
All Articles

Radio Compass Blog

After sartans, diabetes drug metformin being tested for cancer causing impurities; FDA’s overseas inspections drop

This week in Phispers, we bring you the major announcements made by Sanofi’s new CEO Paul Hudson at its strategy meet. The French drugmaker has decided to give up finding new cures for diabetes and heart diseases, and focus on cancer cures. ...
2019-12-12

https://www.pharmacompass.com/radio-compass-blog/after-sartans-diabetes-drug-metformin-being-tested-for-cancer-causing-impurities-fda-s-overseas-inspections-drop

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1326
Share Share info
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty